These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The epidemiology of methamphetamine use and harm in Australia. Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Fetherston J. Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605 [Abstract] [Full Text] [Related]
4. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia. White B, Day C, Degenhardt L, Kinner S, Fry C, Bruno R, Johnston J. Drug Alcohol Depend; 2006 Jul 27; 83(3):210-7. PubMed ID: 16343810 [Abstract] [Full Text] [Related]
9. An investigation of factors associated with depressive symptoms among a sample of regular ecstasy consumers. Matthews AJ, Bruno R. Neuropsychobiology; 2010 Jul 27; 61(4):215-22. PubMed ID: 20389132 [Abstract] [Full Text] [Related]
13. The relationship between crystalline methamphetamine use and methamphetamine dependence. McKetin R, Kelly E, McLaren J. Drug Alcohol Depend; 2006 Dec 01; 85(3):198-204. PubMed ID: 16723192 [Abstract] [Full Text] [Related]
16. Crystal methamphetamine use associated with non-fatal overdose among a cohort of injection drug users in Vancouver. Fairbairn N, Wood E, Stoltz JA, Li K, Montaner J, Kerr T. Public Health; 2008 Jan 01; 122(1):70-8. PubMed ID: 17645904 [Abstract] [Full Text] [Related]
17. The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia. Chalmers J, Bradford D, Jones C. Int J Drug Policy; 2010 Sep 01; 21(5):381-9. PubMed ID: 20619627 [Abstract] [Full Text] [Related]